Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Gate is a Germany-based health technology and medical technology company focused on antimicrobial and antiviral surface technologies for healthcare, hygiene, and selected consumer applications. Its core offerings include silver-based technologies such as HyProtectTM for coating medical implants and MicroSilver BGTM for dermatology, wound care, and veterinary products. The company operates across medical technology, derma cosmetics and wound care, veterinary, and industry/consumer segments, and also provides biological and chemical testing services through its QualityLabs subsidiary. Bio-Gate appears to generate commercial revenue today, while also advancing partner-led regulatory and clinical programs for coated orthopedic implants. The business model combines technology licensing, development support, coating services, product supply, and testing along the value chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Gate.